Stay updated on Naptumomab + Durvalumab in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Naptumomab + Durvalumab in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Naptumomab + Durvalumab in Solid Tumors Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.3%
    Check dated 2025-04-30T16:55:47.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.15.0 from version 2.14.4, indicating a revision in the content. The phrase 'Here’s how you know' has been modified to 'Here's how you know', which does not significantly alter the meaning.
    Difference
    1.0%
    Check dated 2025-04-16T12:44:31.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to March 18, 2025.
    Difference
    0.6%
    Check dated 2025-04-09T05:54:34.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    The page has updated the status of a clinical trial from 'Active, not recruiting' to 'Recruiting' and has changed the trial's end date from February 22, 2024, to March 18, 2025.
    Difference
    4%
    Check dated 2025-03-25T13:43:21.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    5%
    Check dated 2025-02-24T20:21:08.000Z thumbnail image
  8. Check
    87 days ago
    Change Detected
    Summary
    The page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    6%
    Check dated 2025-02-10T09:31:07.000Z thumbnail image

Stay in the know with updates to Naptumomab + Durvalumab in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Naptumomab + Durvalumab in Solid Tumors Clinical Trial page.